Challenges in lung cancer therapy during the COVID-19 pandemic.

Calabrò, L.; Peters, S.; Soria, J.C.; Di Giacomo, A.M.; Barlesi, F.; Covre, A.; Altomonte, M.; Vegni, V.; Gridelli, C.; Reck, M.; Rizvi, N.; Maio, M.

doi:10.1016/S2213-2600(20)30170-3

Challenges in lung cancer therapy during the COVID-19 pandemic.

Details

Download: 32278368_BIB_C8A0BEA4C21E.pdf (665.56 [Ko])
State: Public
Version: Final published version
License: Not specified

Serval ID

serval:BIB_C8A0BEA4C21E

Type

Article: article from journal or magazin.

Collection

Publications

Institution

UNIL/CHUV

Title

Challenges in lung cancer therapy during the COVID-19 pandemic.

Journal

The Lancet. Respiratory medicine

Author(s)

Calabrò L., Peters S., Soria J.C., Di Giacomo A.M., Barlesi F., Covre A., Altomonte M., Vegni V., Gridelli C., Reck M., Rizvi N., Maio M.

ISSN

2213-2619 (Electronic)

ISSN-L

2213-2600

Publication state

Published

Issued date

06/2020

Peer-reviewed

Oui

Volume

8

Number

6

Pages

542-544

Language

english

Notes

Publication types: Journal Article
Publication Status: ppublish

Keywords

Antineoplastic Agents/adverse effects, Betacoronavirus, Coronavirus Infections/complications, Coronavirus Infections/virology, Drug-Related Side Effects and Adverse Reactions/virology, Humans, Lung Neoplasms/drug therapy, Lung Neoplasms/virology, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/virology

URN

urn:nbn:ch:serval-BIB_C8A0BEA4C21E5

OAI-PMH

oai:serval.unil.ch:BIB_C8A0BEA4C21E

DOI

10.1016/S2213-2600(20)30170-3

Pubmed

32278368

Web of science

000540618400019

Open Access

Yes